Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Moldir TUYSKANOVA"'
Autor:
Muratbay Mambetaliyev, Sanat Kilibayev, Marzhan Kenzhebaeva, Nuraiym Sarsenkulova, Shalkar Tabys, Aisulu Valiyeva, Dias Muzarap, Moldir Tuyskanova, Balzhan Myrzakhmetova, Nurkuisa Rametov, Aizhamal Sarbassova, Ryspek Nurgaziev, Aslan Kerimbayev, Shawn Babiuk, Kuandyk Zhugunissov
Publikováno v:
Vaccines, Vol 12, Iss 6, p 685 (2024)
An outbreak of camelpox occurred in the Mangistau region of Kazakhstan in 2019. To control the outbreak of camelpox and to prevent its further spread to other regions, camels were vaccinated using live and inactivated camelpox vaccines produced in Ka
Externí odkaz:
https://doaj.org/article/b7f791d5431948eea320c0fbb9bce393
Autor:
Kuandyk Zhugunissov, Kunsulu Zakarya, Berik Khairullin, Mukhit Orynbayev, Yergali Abduraimov, Markhabat Kassenov, Kulyaisan Sultankulova, Aslan Kerimbayev, Sergazy Nurabayev, Balzhan Myrzakhmetova, Aziz Nakhanov, Ainur Nurpeisova, Olga Chervyakova, Nurika Assanzhanova, Yerbol Burashev, Muratbay Mambetaliyev, Moldir Azanbekova, Syrym Kopeyev, Nurlan Kozhabergenov, Aisha Issabek, Moldir Tuyskanova, Lespek Kutumbetov
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
In March 2020, the first cases of the human coronavirus disease COVID-19 were registered in Kazakhstan. We isolated the SARS-CoV-2 virus from clinical materials from some of these patients. Subsequently, a whole virion inactivated candidate vaccine,
Externí odkaz:
https://doaj.org/article/e6566ebc4b064a139619de8c493998fe
Autor:
Moldir TUYSKANOVA, Kuandyk ZHUGUNISSOV, Mehmet OZASLAN, Aziz NAKHANOV, Kunsulu ZAKARYA, Moldir AZANBEKOVA, Marzhan KENZHEBAEVA, Alisher OMURTAY, Arailym DZHAPASHEVA, Muratbay MAMBETALIYEV, Shalkar TABYS, Balzhan MYRZAKHMETOVA, Lespek KUTUMBETOV
Publikováno v:
The Eurasia Proceedings of Health, Environment and Life Sciences. 5:40-47
In early December 2019, humanity faced a new problem caused by a coronavirus. An epidemic event capable of causing severe primary viral pneumonia in humans began to develop in the central Chinese province of Hubei. The isolated etiological agent was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a2811021e4aad75a710a6b252e107fc8
https://doi.org/10.55549/ephels.33
https://doi.org/10.55549/ephels.33
Autor:
Muratbay Mambetaliyev, Syrym Kopeyev, Moldir Azanbekova, Kulyaisan Sultankulova, Aziz Nakhanov, Nurlan Kozhabergenov, Olga V. Chervyakova, Markhabat Kassenov, Yerbol Burashev, Sergazy Nurabayev, Balzhan Myrzakhmetova, Kuandyk Zhugunissov, Lespek Kutumbetov, Kunsulu Zakarya, Ainur Nurpeisova, Moldir Tuyskanova, Mukhit Orynbayev, Berik Khairullin, Nurika Assanzhanova, Aslan Kerimbayev, Yergali Abduraimov, Aisha Issabek
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
Frontiers in Microbiology
Frontiers in Microbiology
In March 2020, the first cases of human coronavirus infection COVID-19 were registered in Kazakhstan. We isolated the SARS-CoV-2 virus from the clinical material from the patients. Subsequently, a whole virion inactivated candidate vaccine, QazCovid-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6d357e6df5fe6d38891cafd564e1eeb
https://www.frontiersin.org/articles/10.3389/fmicb.2021.720437/full
https://www.frontiersin.org/articles/10.3389/fmicb.2021.720437/full